Clinical Trial Update: Sodic Heparin Effectiveness of the Treatment of Burns [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial NCT00701623 evaluating sodic heparin for burns has been withdrawn after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• sodic heparin (sodic heparin)

Snippet

Sponsor: Azidus Brasil | Conditions: Burns | Phase 2, Phase 3 | Status: WITHDRAWN